Intech Investment Management LLC Sells 55,714 Shares of Cardinal Health, Inc. $CAH

Intech Investment Management LLC lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 208,541 shares of the company’s stock after selling 55,714 shares during the period. Intech Investment Management LLC owned 0.09% of Cardinal Health worth $42,855,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its holdings in shares of Cardinal Health by 2.0% during the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after purchasing an additional 617,775 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Cardinal Health by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after purchasing an additional 43,924 shares during the last quarter. Wellington Management Group LLP boosted its holdings in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after acquiring an additional 3,511,579 shares during the last quarter. Bank of America Corp DE boosted its holdings in Cardinal Health by 3.2% in the third quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock valued at $563,922,000 after acquiring an additional 111,582 shares during the last quarter. Finally, Invesco Ltd. boosted its holdings in Cardinal Health by 14.7% in the third quarter. Invesco Ltd. now owns 3,483,207 shares of the company’s stock valued at $546,724,000 after acquiring an additional 445,425 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.2%

NYSE:CAH opened at $199.53 on Friday. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60. The business’s 50-day moving average price is $203.82 and its two-hundred day moving average price is $208.88. The firm has a market capitalization of $46.73 billion, a price-to-earnings ratio of 30.51, a PEG ratio of 1.19 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the firm posted $2.35 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 1.0%. Cardinal Health’s payout ratio is currently 31.19%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. William Blair assumed coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Barclays raised their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a report on Tuesday, February 24th. Mizuho raised their price target on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a report on Friday, February 6th. Finally, Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.